Sort
48,018 grants matching “immunotherapy”
CD19-Specific Central Memory T Cell Adoptive Immunotherapy for Non-Hodgkin Lymphoma
$1,152,253Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P50 · FY2014 · CA
Strategies for Cancer Immunotherapy Clinical Trials
$1,151,937Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,151,937Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response
$1,151,331Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression
$1,151,331Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
TARGETING BASAL-LIKE PROSTATE CANCER WITH CADHERIN 3 ANTIBODY-DRUG CONJUGATE AS SINGLE AGENT AND IN COMBINATION WITH IMMUNOTHERAPY
$1,150,994University Of Notre Dame Du Lac · · FY2020 · Defense Health Agency
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,150,820Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform
$1,150,319Shawn Hingtgen · Univ Of North Carolina Chapel Hill · U01 · FY2022 · TR
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
$1,150,263Jonathan P Schneck · Johns Hopkins University · P41 · FY2021 · EB
Cytokines and T Cell Development
$1,150,207Scott Durum · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies
$1,150,207Jing Zhou · Isoplexis, Inc. · R44 · FY2021 · CA
A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies
$1,150,207Jing Zhou · Isoplexis, Inc. · R44 · FY2020 · CA
SPORE in Lymphoma
$1,150,000Richard F. Ambinder · Johns Hopkins University · P50 · FY2007 · CA
UNIVERSITY OF TEXAS MD ANDERSON SPORE IN OVARIAN CANCER
$1,150,000University Of Texas Md Anderson Can Ctr · P50 · FY2004 · CA
The Johns Hopkins Translational ImmunoEngineering (JH-TIE)
$1,149,953Jonathan P Schneck · Johns Hopkins University · P41 · FY2025 · EB
Pediatric Solid Tumor Microenvironment Atlas
$1,149,870Shahab Asgharzadeh · Children'S Hospital Of Los Angeles · U01 · FY2024 · CA
Bay Area Team Against Resistance
$1,149,528Trever G Bivona · University Of California, San Francisco · U54 · FY2021 · CA
Immunotherapeutics Against Arenaviruses
$1,149,274Robert F Garry · Scripps Research Institute, The · U19 · FY2018 · AI
NORTHERN CALIFORNIA PEDIATRIC AIDS TREATMENT CENTER
$1,149,037University Of California San Francisco · U01 · FY2001 · AI
Protein Expression Facility
$1,148,759Robert Petrovich · National Institute Of Environmental Health Sciences · ZIC · FY2025 · ES
Developing Novel Therapies for High Risk Pediatric Cancers
$1,148,695Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
TOLERANCE TO ISLET ALLOGRAFTS IN TYPE I DIABETES
$1,148,530University Of Minnesota Twin Cities · R01 · FY2004 · DK
Unlocking evolutionarily latent immune functions for treating disease
$1,148,267Brenda L. Bass · University Of Utah · R01 · FY2021 · CA
Childhood Cancer Data Initiative
$1,147,549Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZID · FY2025 · CA
Roswell Park Ovarian Cancer SPORE
$1,147,484Kirsten B Moysich · Roswell Park Cancer Institute Corp · P50 · FY2023 · CA